Christina is the associate editorial director of The American Journal of Managed Care® (AJMC®) and The American Journal of Accountable Care® (AJAC), and joined AJMC in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.
She has a BS in public health from Rutgers University. You can connect with Christina on LinkedIn.
The Far-Reaching Effects of Health Disparities on the Gut Microbiome and Health
May 22nd 2022Speakers at Digestive Disease Week 2022 presented research on how health disparities and socioeconomic factors can contribute to changes in the gut microbiome that have implications for cancer risk, immune health, and overall well-being.
Use of AI in Gastroenterology Can Move Beyond “Cool Tools” to Improve Practice Efficiency
May 21st 2022As artificial intelligence (AI) technology in the gastrointestinal field continues to advance, speakers at Digestive Disease Week 2022 discussed how these tools can be put into practice to improve efficiency, reduce physician burnout, and reap cost savings.
Despite Expanding Array of Psoriasis Treatments, Opportunities for Improvement Remain
April 23rd 2021There are a number of new biologic options for treating psoriasis, but undertreatment is still a concern, and more long-term data are needed, according to Junko Takeshita, MD, PhD, MSCE, at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.
New Understanding of Migraine Biology Paves Way for Innovative Therapy Options
April 23rd 2021Now that investigators have a better understanding of the biological mechanisms of migraine, new treatment and prevention options are making their way to patients and fueling an exciting time for the field, according to a presenter at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.
Overcoming the Unique Hurdles to Biosimilar Uptake in Oncology
April 23rd 2021With the costs of biologic drugs increasing, biosimilars have emerged as an attractive option for containing costs and expanding access to treatment. However, some barriers to wider uptake still need to be addressed, according to a presentation at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.
Top 5 Most-Read Multiple Sclerosis Articles of 2020
December 27th 2020The coronavirus disease 2019 (COVID-19) pandemic dominated headlines for much of 2020, and most of the top 5 multiple sclerosis articles of this year discussed the effects of COVID-19 on patients with this disease. Others touched on physician and patient assessments of relapse and potential new treatments for neural damage.
Top 5 Most-Read Inflammation Articles of 2020
December 23rd 2020This year, the most popular articles and interviews related to the role of inflammation in asthma and other conditions touched on the mechanisms of inflammation, patterns of inhaler use, and the real-world impacts of the monoclonal antibody dupilumab.
Moving Beyond Precision Oncology to “Precision Prevention” in Oncology Practices
November 11th 2020In a pair of sessions at the Quality Cancer Care Alliance Virtual Fall Leadership Summit, speakers discussed the promise of precision medicine for not only informing individuals’ cancer treatment decisions but also identifying individuals at high risk before disease develops.
Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs
October 23rd 2020In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.
Understanding the Complicated Patchwork of State Drug Pricing Reform Legislation
October 23rd 2020The pressure on state budgets exerted by new approvals of costly therapeutics has led many states to implement legislation aimed at regulating drug prices, but the success of these efforts is not uniform across the nation.
Succeeding in Value-Based Payment Requires Engaging Pharmacists From Health Plans and Systems
October 21st 2020Pharmacists have an important role to play in the success of value-based payment models, according to panelists who discussed their health plan’s value initiatives at the Academy of Managed Care Pharmacy Nexus 2020 meeting.
Keeping Up With Pharmacists’ Changing Scope of Practice Amid COVID-19
October 21st 2020A panel discussion examined the changes in the health care landscape occurring due to the coronavirus disease 2019 (COVID-19) pandemic, particularly around pharmacists’ scope of practice, and which changes are likely to persist after the pandemic.
Makary Calls for Price Reform, Transparency to Fulfill Patient-Centered Medical Heritage
October 20th 2020Marty Makary, MD, MPH, kicked off the Academy of Managed Care Pharmacy Nexus 2020 meeting with a call to action around reducing overprescribing, increasing price transparency, and recapturing the public’s trust in the health care system.